Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children

Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children

The purpose of this study is to determine whether a nutritional supplement is effective in the treatment of malnutrition in pediatric patients with failure to thrive or cystic fibrosis.

This is a multicenter, controlled, randomized, prospective, parallel-group, double-blind study to evaluate the effect of a nutritional supplement on nutritional status in children with failure to thrive or cystic fibrosis. Patients will be randomized to receive either a symbiotic formula with DHA and antioxidants or a standard formula.

Inclusion Criteria:

• Malnutrition (P / T <-1 SD) by intake deficit without organic disease (failure to thrive) and / or patients diagnosed with Cystic Fibrosis).
• Age >= 1 year.
• Stable patients
• No antibiotherapy in the last 30 days
• Inform consent signed (parent/legal representative)

Exclusion Criteria:

• Patients with allergy / intolerance to cow's milk proteins
• Metabolically unstable patient
• Patients with metabolic intolerance to carbohydrates
• Patients with severe disease in the last 30 days